<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p105" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_105{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#t2_105{left:285px;bottom:827px;letter-spacing:-0.27px;}
#t3_105{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t4_105{left:341px;bottom:30px;}
#t5_105{left:348px;bottom:25px;letter-spacing:0.11px;}
#t6_105{left:377px;bottom:30px;}
#t7_105{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t8_105{left:540px;bottom:30px;}
#t9_105{left:546px;bottom:25px;letter-spacing:0.07px;}
#ta_105{left:44px;bottom:77px;letter-spacing:0.1px;word-spacing:-0.05px;}
#tb_105{left:44px;bottom:63px;letter-spacing:0.1px;}
#tc_105{left:996px;bottom:873px;letter-spacing:-0.1px;}
#td_105{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#te_105{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#tf_105{left:1118px;bottom:47px;letter-spacing:0.32px;}
#tg_105{left:1121px;bottom:28px;letter-spacing:0.19px;word-spacing:-0.15px;}
#th_105{left:35px;bottom:748px;letter-spacing:-0.1px;}
#ti_105{left:35px;bottom:729px;letter-spacing:-0.09px;}
#tj_105{left:40px;bottom:711px;}
#tk_105{left:57px;bottom:711px;letter-spacing:-0.1px;word-spacing:0.01px;}
#tl_105{left:57px;bottom:693px;letter-spacing:-0.09px;}
#tm_105{left:40px;bottom:674px;}
#tn_105{left:57px;bottom:674px;letter-spacing:-0.09px;}
#to_105{left:57px;bottom:656px;letter-spacing:-0.09px;}
#tp_105{left:40px;bottom:638px;}
#tq_105{left:57px;bottom:638px;letter-spacing:-0.09px;}
#tr_105{left:57px;bottom:619px;letter-spacing:-0.09px;}
#ts_105{left:35px;bottom:587px;letter-spacing:-0.09px;}
#tt_105{left:35px;bottom:569px;}
#tu_105{left:45px;bottom:569px;letter-spacing:-0.1px;word-spacing:0.01px;}
#tv_105{left:46px;bottom:551px;letter-spacing:-0.09px;}
#tw_105{left:46px;bottom:532px;letter-spacing:-0.23px;}
#tx_105{left:1145px;bottom:540px;letter-spacing:-0.42px;}
#ty_105{left:40px;bottom:514px;}
#tz_105{left:57px;bottom:514px;letter-spacing:-0.13px;word-spacing:0.04px;}
#t10_105{left:57px;bottom:496px;letter-spacing:-0.09px;}
#t11_105{left:57px;bottom:477px;letter-spacing:-0.1px;}
#t12_105{left:124px;bottom:485px;}
#t13_105{left:40px;bottom:459px;}
#t14_105{left:57px;bottom:459px;letter-spacing:-0.11px;word-spacing:0.02px;}
#t15_105{left:57px;bottom:441px;letter-spacing:-0.09px;}
#t16_105{left:40px;bottom:422px;}
#t17_105{left:57px;bottom:422px;letter-spacing:-0.09px;}
#t18_105{left:35px;bottom:404px;}
#t19_105{left:45px;bottom:404px;letter-spacing:-0.13px;word-spacing:0.04px;}
#t1a_105{left:46px;bottom:386px;letter-spacing:-0.09px;}
#t1b_105{left:46px;bottom:367px;letter-spacing:-0.09px;}
#t1c_105{left:46px;bottom:349px;letter-spacing:-0.09px;}
#t1d_105{left:46px;bottom:331px;letter-spacing:-0.09px;}
#t1e_105{left:40px;bottom:312px;}
#t1f_105{left:57px;bottom:312px;letter-spacing:-0.09px;}
#t1g_105{left:35px;bottom:294px;}
#t1h_105{left:45px;bottom:294px;letter-spacing:-0.09px;}
#t1i_105{left:46px;bottom:276px;letter-spacing:-0.09px;}
#t1j_105{left:46px;bottom:257px;letter-spacing:-0.09px;}
#t1k_105{left:40px;bottom:239px;}
#t1l_105{left:57px;bottom:239px;letter-spacing:-0.13px;word-spacing:0.03px;}
#t1m_105{left:35px;bottom:221px;}
#t1n_105{left:45px;bottom:221px;letter-spacing:-0.1px;word-spacing:-0.03px;}
#t1o_105{left:46px;bottom:202px;letter-spacing:-0.09px;}
#t1p_105{left:35px;bottom:184px;}
#t1q_105{left:45px;bottom:184px;letter-spacing:-0.09px;}
#t1r_105{left:46px;bottom:166px;letter-spacing:-0.09px;}
#t1s_105{left:46px;bottom:147px;letter-spacing:-0.1px;}
#t1t_105{left:36px;bottom:131px;}
#t1u_105{left:46px;bottom:125px;letter-spacing:0.12px;word-spacing:-0.05px;}
#t1v_105{left:45px;bottom:108px;letter-spacing:0.09px;}
#t1w_105{left:1091px;bottom:95px;letter-spacing:-0.11px;}
#t1x_105{left:413px;bottom:778px;letter-spacing:0.4px;word-spacing:-0.23px;}
#t1y_105{left:772px;bottom:786px;letter-spacing:-0.12px;}
#t1z_105{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_105{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s1_105{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.s2_105{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.s3_105{font-size:12px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_105{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.s5_105{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s6_105{font-size:17px;font-family:Webdings_k6;color:#000;}
.s7_105{font-size:17px;font-family:Arial-BoldMT_jz;color:#000;}
.s8_105{font-size:14px;font-family:Arial-BoldMT_5te;color:#000;}
.s9_105{font-size:12px;font-family:ArialMT_5tg;color:#000;}
.sa_105{font-size:15px;font-family:ArialMT_5tg;color:#000;}
.sb_105{font-size:15px;font-family:ArialMT_5tg;color:#0065A4;}
.sc_105{font-size:17px;font-family:Arial-BoldMT_5te;color:#0065A4;}
.sd_105{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts105" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-BoldMT_jz;
	src: url("fonts/Arial-BoldMT_jz.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

@font-face {
	font-family: Webdings_k6;
	src: url("fonts/Webdings_k6.woff") format("woff");
}

</style>
<div id="pg105Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg105" style="-webkit-user-select: none;"><object width="1210" height="935" data="105/105.svg" type="image/svg+xml" id="pdf105" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_105" class="t s0_105">NCCN Guidelines Version 4.2024 </span>
<span id="t2_105" class="t s0_105">Head and Neck Cancers </span>
<span id="t3_105" class="t s1_105">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t4_105" class="t s2_105">® </span>
<span id="t5_105" class="t s1_105">(NCCN </span>
<span id="t6_105" class="t s2_105">® </span>
<span id="t7_105" class="t s1_105">), All rights reserved. NCCN Guidelines </span>
<span id="t8_105" class="t s2_105">® </span>
<span id="t9_105" class="t s1_105">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="ta_105" class="t s3_105">Note: All recommendations are category 2A unless otherwise indicated. </span>
<span id="tb_105" class="t s3_105">Clinical Trials: NCCN believes that the best management of any patient with cancer is in a clinical trial. Participation in clinical trials is especially encouraged. </span>
<span id="tc_105" class="t s4_105">NCCN Guidelines Index </span>
<span id="td_105" class="t s4_105">Table of Contents </span>
<span id="te_105" class="t s4_105">Discussion </span>
<span id="tf_105" class="t s5_105">RAD-A </span>
<span id="tg_105" class="t s5_105">1 OF 7 </span>
<span id="th_105" class="t s5_105">Assessment of Radiotherapy </span>
<span id="ti_105" class="t s5_105">• All patients should be evaluated by a radiation oncologist prior to treatment to ensure the following: </span>
<span id="tj_105" class="t s6_105"></span><span id="tk_105" class="t s5_105">Review staging and imaging to determine the extent of disease, exclude the presence of a synchronous primary tumor, assess functional </span>
<span id="tl_105" class="t s5_105">status, and evaluate for potential RT options. </span>
<span id="tm_105" class="t s6_105"></span><span id="tn_105" class="t s5_105">Participate in the multidisciplinary team discussions regarding patient treatment options with the goal of maximizing survival with </span>
<span id="to_105" class="t s5_105">preservation of form and function. </span>
<span id="tp_105" class="t s6_105"></span><span id="tq_105" class="t s7_105">Develop a prospective surveillance plan that includes adequate dental, swallowing, nutritional, and health behavior evaluation and </span>
<span id="tr_105" class="t s5_105">intervention and any other ancillary evaluations that would provide for comprehensive rehabilitation. </span>
<span id="ts_105" class="t s5_105">General Principles </span>
<span id="tt_105" class="t s5_105">• </span><span id="tu_105" class="t s7_105">Target delineation and optimal dose distribution require experience in head and neck imaging and a thorough understanding of patterns of </span>
<span id="tv_105" class="t s7_105" data-mappings='[[39,"fi"],[58,"fi"]]'>disease spread. Standards for target deﬁnition, dose speciﬁcation, fractionation (with and without concurrent chemotherapy), and normal </span>
<span id="tw_105" class="t s5_105">tissue constraints are still evolving. Published contouring guidelines referenced are in regard to patients who have not been operated upon. </span>
<span id="tx_105" class="t s8_105">10,11 </span>
<span id="ty_105" class="t s6_105"></span><span id="tz_105" class="t s7_105">IMRT (preferred) or other conformal techniques (3D-CRT, helical tomotherapy, volumetric modulated arc therapy [VMAT], and proton beam </span>
<span id="t10_105" class="t s5_105">therapy [PBT]) may be used as appropriate depending on the stage, tumor location, physician training/experience, and available physics </span>
<span id="t11_105" class="t s5_105">support. </span>
<span id="t12_105" class="t s8_105">a </span>
<span id="t13_105" class="t s6_105"></span><span id="t14_105" class="t s7_105">Close interplay exists between radiation technology, techniques, fractionation, cumulative radiation dose, surgery, and chemotherapy </span>
<span id="t15_105" class="t s5_105">options resulting in a large number of combinations that may impact toxicity or tumor control. </span>
<span id="t16_105" class="t s6_105"></span><span id="t17_105" class="t s5_105">FDG-PET/CT or MRI with contrast can be used for fusion in treatment planning. </span>
<span id="t18_105" class="t s5_105">• </span><span id="t19_105" class="t s7_105" data-mappings='[[107,"ff"]]'>Advanced RT technologies such as IMRT (preferred), tomotherapy, VMAT, image-guided RT (IGRT), and PBT may oﬀer clinically relevant </span>
<span id="t1a_105" class="t s7_105" data-mappings='[[19,"fi"]]'>advantages in speciﬁc instances to spare important organs at risk (OARs), such as the brain, brain stem, cochlea, semicircular canals, </span>
<span id="t1b_105" class="t s5_105">optic chiasm and cranial nerves, retina, lacrimal glands, cornea, spinal cord, brachial plexus, mucosa, salivary glands, bone (skull base and </span>
<span id="t1c_105" class="t s5_105">mandible), pharyngeal constrictors, larynx, and esophagus, and decrease the risk for late, normal tissue damage while still achieving the </span>
<span id="t1d_105" class="t s5_105">primary goal of local tumor control. </span>
<span id="t1e_105" class="t s6_105"></span><span id="t1f_105" class="t s7_105" data-mappings='[[37,"fi"],[72,"fl"]]'>The demonstration of clinically signiﬁcant dose-sparing of these OARs reﬂects best clinical practice. </span>
<span id="t1g_105" class="t s5_105">• </span><span id="t1h_105" class="t s7_105" data-mappings='[[126,"fi"]]'>Since the advantages of these techniques include tightly conformal doses and steep gradients next to normal tissues, target deﬁnition </span>
<span id="t1i_105" class="t s7_105" data-mappings='[[43,"fi"]]'>and delineation and treatment delivery veriﬁcation require careful monitoring to avoid the risk of tumor geographic miss and subsequent </span>
<span id="t1j_105" class="t s5_105">decrease in local tumor control. </span>
<span id="t1k_105" class="t s6_105"></span><span id="t1l_105" class="t s7_105" data-mappings='[[120,"fi"]]'>Initial diagnostic imaging with contrast-enhanced CT, MRI, FDG-PET/CT, and other imaging modalities facilitate target deﬁnition. </span>
<span id="t1m_105" class="t s5_105">• </span><span id="t1n_105" class="t s7_105">Image guidance is required to provide assurance of accurate daily delivery. Anatomical changes including rapidly shrinking tumors, changes </span>
<span id="t1o_105" class="t s7_105" data-mappings='[[25,"fi"]]'>in air cavities, or signiﬁcant weight loss may necessitate repeat diagnostic imaging and replanning (adaptive treatment). </span>
<span id="t1p_105" class="t s5_105">• </span><span id="t1q_105" class="t s7_105" data-mappings='[[87,"fi"]]'>Randomized studies to test these concepts are unlikely to be done since the above speciﬁc clinical scenarios represent complex </span>
<span id="t1r_105" class="t s7_105">combinations of multiple variables. In light of that, the modalities and techniques that are found best to reduce the doses to the clinically </span>
<span id="t1s_105" class="t s5_105">relevant OARs without compromising target coverage should be considered. </span>
<span id="t1t_105" class="t s9_105">a </span>
<span id="t1u_105" class="t sa_105">For additional resources regarding the technical details of radiation, see the American College of Radiology Guidelines: </span>
<span id="t1v_105" class="t sb_105">https://www.acr.org/Clinical-Resources/Practice-Parameters-and-Technical-Standards </span>
<span id="t1w_105" class="t sc_105">Continued </span>
<span id="t1x_105" class="t s7_105">PRINCIPLES OF RADIATION TECHNIQUES </span>
<span id="t1y_105" class="t s8_105">1-9 </span>
<span id="t1z_105" class="t sd_105">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
